Top Banner
© 2015 akshay anand AND MOBILE APPS FDA MEDICAL REGULATORY APPROACH AKSHAY ANAND M I Year Master of Pharmacy Pharmaceutical Regulatory Affairs JSS College Of Pharmacy Mysuru 570015, Karnataka
19
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Mobile Medical Apps and FDA Regulatory Approach

©2015akshayanand

AND

MOBILEAPPS

FDAMEDICAL

REGULATORYAPPROACH

AKSHAY ANAND M

I Year – Master of Pharmacy

Pharmaceutical Regulatory Affairs

JSS College Of Pharmacy

Mysuru 570015, Karnataka

Page 2: Mobile Medical Apps and FDA Regulatory Approach

MOBILE MEDICAL APP• A mobile app is a computer program designed to run on smartphones, tablet

computers and other mobile devices.

• Apps are usually available through application distribution platform, which beganappearing in 2008 and are typically operated by the owner of the mobile operatingsystem, such as the Apple App Store, Google Play, Windows Phone Store, andBlackBerry App World.

• The terms medical software and medical device software are undefined terms thatcan designate any software, software item or system used within a medicalcontext (e.g. medical devices that monitor or control patients are predominantlycontrolled by software), depending on its intended use / indication for use.

• Mobile Medical Apps are the medical software applications developed as Apps onmultiple platforms as stated above.

1

Page 3: Mobile Medical Apps and FDA Regulatory Approach

ASPECTS

• Mobile App Statistics

• FDA Guidance on Mobile Medical Devices

• When is an App called a Device?

• FDA Criteria for Mobile Medical Apps

• FDA Categories of Mobile Medical Apps

• Medical Device Data System (MDDS)

• FDA Regulatory Process for Mobile Medical Apps

OF THIS PRESENTATION

2

Page 5: Mobile Medical Apps and FDA Regulatory Approach

FDA Guidanceon Mobile Medical Devices

Highly anticipated FDA guidancereleased in July 2011 indicates whichmobile medical apps fall undermedical device regulatoryrequirements, and which do not.Although not all types of mobilemedical apps are covered by theguidance, the FDA’s proposed rulesshow that the agency will not betaking a one-size-fits-all approach tothese products.

http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm263280.htm

4

Page 6: Mobile Medical Apps and FDA Regulatory Approach

An App is Likely a Device if it,

But, manufacturers should take intoaccount several criteria, such as their apps’ intended uses and how they interact with other devices, whendetermining whether their productsqualify as medical devices.

AmplifiesAnalyzesAttachesInterprets Assesses AlarmsCalculatesControls Converts

CuresDetectsDiagnosesManipulates MeasuresMonitors ProgramsTrends Treats

5

Page 7: Mobile Medical Apps and FDA Regulatory Approach

FDA Criteria for Determining if anApp is a Medical Device• Is the app a component of a medical device?

• Is the app an accessory to amedical device?

• Is the app intended for use inthe diagnosis, treatment,mitigation or prevention of adisease?

6

If the answer to any one of these questions is yes, theFDA considers the app amedical device.

Page 8: Mobile Medical Apps and FDA Regulatory Approach

FDA Criteria for MobileMedical Apps

Specific criteria for apps as medical devices:

1. Mobile medical apps that serve as extensions of regulatedmedical devices and control those devices or display, store, analyze or transmit patient-specific medical device data

2. Mobile medical apps that transform mobile platformsinto regulated medical devices by using attachments orsimilar medical device functions

3. Mobile medical apps that allow users to input patient-specific data and output patient-specific results ordiagnoses using formulae or processing algorithms

7

Page 9: Mobile Medical Apps and FDA Regulatory Approach

FDA Categories of MobileMedical Apps

The FDA’s guidance lists the following categories of mobile medical apps that qualify as medical devices:• Apps for displaying, storing or transmitting patient-

specific medical device data in its original format• Apps that control intended use, functions or energy

sources of medical devices to which they connect• Apps that transform mobile platforms into medical

devices• Apps that analyze medical device data to create

alarms, recommendations or new information

8

Page 10: Mobile Medical Apps and FDA Regulatory Approach

Mobile Medical App Firms NOTRegulated by the FDAFirms that distribute mobile medical but do

not actually develop and/or manufacture

those products are not considered mobile

medical app manufacturers.

9

Page 11: Mobile Medical Apps and FDA Regulatory Approach

Medical Device Data SystemsThe FDA’s Medical Device DataSystems (MDDS) category ofdevices covers products used totransfer, store, convert or displaymedical device data. Devicesfalling under the MDDS aredesignated as Class I, and areexempt from FDA premarketnotification requirements in theUS. Some mobile medical appsalso fall under this category.

10

Page 12: Mobile Medical Apps and FDA Regulatory Approach

Does Your App Qualifyas MDDS?

Devices that provide one or more of the following functions without controlling or altering how connected devices operatequalify as MDDS products:

The scope of MDDS can include mobile medical apps as well as software,hardware, modems, interfaces and communication protocols.

• Electronic transfer of medical device data• Electronic storage of medical device data• Electronic display of medical device data

11

Page 13: Mobile Medical Apps and FDA Regulatory Approach

The US FDA RegulatoryProcess for Medical Devices

Mobile medical apps fall under the same regulatory requirementsas other medical devices. Whether an app is classified as Class I, IIor III depends on the level of risk it poses to users, as well aswhether Substantial Equivalence exists.

12

Page 14: Mobile Medical Apps and FDA Regulatory Approach

FDA Clearance or ApprovalMobile medical apps can fall into any of these three classes.

Class I Class II Class III

No FDA reviewneeded.

FDA clearance required via510(k) Premarket

Notification. Predicate; “Me too” devices.

FDA approval required via Premarket Approval (PMA) process. Novel;

no predicates.

Class I Class II Class III

Process typicallytakes 5 to 7 workingdays. Self-register

your device and payFDA fee. Some Class 1products do require a

510(k) submission.

Most 510(k) applications reviewed within 90 days, but the entire

process can take between 4 and 10 months. Average timeline is 132

days from submission to FDA clearance…for all products.

Process takes 36 months ormore depending on clinicaltrial requirements and FDA

requests for additionalinformation. Premarket

approval reviews take 180days.

Approval Timelines

13

Page 15: Mobile Medical Apps and FDA Regulatory Approach

Below are broad steps manufacturers of Class I, II and III medical devices must typically

go through to obtain clearance or approval from the US FDA.

Steps in FDA Compliance Process

Determine device classification.

Prepare and file 510(k) submission, if required.

Comply with FDA QSR – 21 CFR Part 820.

Appoint US Agent, if outside US.

Register with FDA.

Pay fee.14

Page 16: Mobile Medical Apps and FDA Regulatory Approach

Quality System RequirementsClass I and all Class II and III medical devices, including mobile medical apps, must implement quality management systems compliant with FDA Quality System Regulations (QSR) found in 21 CFR Part 820

• The FDA does not recognize ISO 13485 or ISO 9001certification—only QSR (aka current Good ManufacturingPractice) compliance is accepted in the US.

• The FDA does not certify quality systems. Instead, the agencyconducts random inspections to determine QSR compliance.

• Even if a manufacturer outsources production of a device or app,that firm must still comply with quality system requirements.

15

Page 17: Mobile Medical Apps and FDA Regulatory Approach

Summary The mobile medical app market has only begun to take off.

Most apps already registered with the FDA have gone through the510(k) review process—but manufacturers should not assume that premarket notification will be the de facto path to market for these products.

2011 FDA guidance on mobile medical app regulation indicates that existing US medical device regulatory structures will be applied to medical apps as well.

App manufacturers new to the FDA regulatory process shouldfamiliarize themselves with issues such as 510(k) clearance, Medical Device Data Systems and FDA Good Manufacturing Practices.

16

Page 18: Mobile Medical Apps and FDA Regulatory Approach

References FDA Guidance Document on Mobile Medical App Regulations

17

Page 19: Mobile Medical Apps and FDA Regulatory Approach

©2015akshayanand

[email protected]